Charles Raison, MD
Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families; Professor, Human Development and Family Studies, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin- Madison, Director of Clinical and Translational Research, Usona Institute,
University of Wisconsin-Madison
Patients with co-occurring disorders such as major depressive disorder (MDD) and substance use disorder (SUD) or MDD and bipolar disorder (BD) experience especially poor outcomes and represent a distinct clinical challenge for providers. Moreover, the addition of a mixed specifier to the DSM-5 has identified an overlooked, high-risk patient population that suffers from subsyndromal concurrent MDD/BD but has also led to a host of questions regarding the identification and management of these patients. This session will explore the unique diagnostic and treatment challenges presented by this patient population through a series of interactive, role-play scenarios that illustrate these challenges on a case-by-case basis.
Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.